Balance Sheet for Sarepta Therapeutics Inc. (SRPT)

$ 169.78   3.02 (+1.81%) Volume: 277.76k 1:55 PM EDT 15-Jul-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 835 371 600 122 80
Restrictable Cash - - - 11 11
Marketable Securities 290 803 479 195 112
Accounts Receivable 90 48 29 5 4
Loans Receivable - - - - -
Other Receivables 4 14 1 - -
Receivables 94 63 29 5 4
Inventories, Raw Materials 82 71 54 10 -
Inventories, Work in Progress 88 47 27 3 -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 1 7 2 0 -
Inventories, Other 171 125 84 13 -
Inventories, Adjustments & Allowances - - - - -
Inventories 171 125 84 13 -
Prepaid Expenses 74 57 33 26 16
Current Deferred Income Taxes - - - - -
Other Current Assets 5 8 37 1 1
Total Current Assets 1,469 1,426 1,229 373 225
Land and Improvements 9 4 4 4 4
Buildings and Improvement 77 44 28 36 34
Machinery, Furniture and Equipment 69 37 21 24 22
Construction in Progress 26 40 8 4 2
Fixed Assets, Other 38 - - - -
Fixed Assets, Total 219 125 61 68 62
Gross Fixed Assets 219 125 61 68 62
Accumulated Depreciation (51) (28) (18) (30) (25)
Net Fixed Assets 168 97 43 38 37
Intangibles 12 12 14 8 7
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 12 2 22 1 1
Total Non-Current Assets 354 216 79 51 49
Total Assets 1,823 1,642 1,308 424 274
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 68 34 8 30 20
Short Term Debt - 13 6 10 8
Notes Payable - - - - -
Accrued Expenses 97 83 46 22 21
Accrued Liabilities 97 83 46 22 21
Deferred Revenues 11 3 3 3 3
Current Deferred Income Taxes - - - - -
Other Current Liabilities 89 41 24 10 9
Total Current Liabilities 265 174 88 75 62
Long Term Debt 682 421 425 6 15
Deferred Income Tax 11 16 6 6 6
Other Non-Current Liabilities 10 16 6 6 6
Minority Interest - - - - -
Capital Lease Obligations 48 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 740 436 430 12 21
Total Liabilities 1,005 610 519 87 83
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 818 1,032 789 337 190
Common Par 0 0 0 0 0
Additional Paid in Capital 3,112 2,611 2,007 1,503 1,090
Cumulative Translation Adjustments - - - - -
Retained Earnings (2,294) (1,579) (1,217) (1,166) (899)
Treasury Stock - - - - -
Other Equity Adjustments 0 (0) (0) (0) (0)
Total Capitalization 1,500 1,453 1,214 343 205
Total Equity 818 1,032 789 337 190
Total Liabilities & Shareholder's Equity 1,823 1,642 1,308 424 274
Cash Flow (737) (366) (58) (273) (226)
Working Capital 1,204 1,252 1,140 298 162
Free Cash Flow (519) (453) (253) (253) (154)
Invested Capital 1,500 1,453 1,214 343 205
Shares Outstanding - Common Class Only 75 71 65 55 46
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 75 71 65 55 46
Total Common Shares Outstanding 75 71 65 55 46
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 74 66 59 49 42
Diluted Weighted Shares Outstanding 74 66 59 49 42